57
19
1
49
2
2
f
1b
1d
18
2b
63
1d
2 29
1d
25
Andrew Dancis
88
63
Emeritus Associate Professor of Medicine (Hematology-Oncology)
7
5f
Department: Medicine
4
1
b
1d
46
Contact information
56
4
3
23
56
15 Meredith Road
Wynnewood, PA 19096
26
Wynnewood, PA 19096
30
Office: (215) 359-7611
30
9d
12
30
1f
Graduate Group Affiliations
8
a
3
1d
18
Publications
23 a
3
2
4
b
1f
23 a
13
Education:
21 9 B.A. 17 (Philosophy) c
2d Princeton University, 1973.
21 9 M.D. 15 (Medicine) c
2c New York University, 1978.
c
3
27
21 9 B.A. 17 (Philosophy) c
2d Princeton University, 1973.
21 9 M.D. 15 (Medicine) c
2c New York University, 1978.
c
Links
97 Search PubMed for articles
b7 Penn Biomedical Graduate Studies, Cell and Molecular Biology Graduate Group
86 Department of Medicine faculty webpage.
c
5
21
97 Search PubMed for articles
b7 Penn Biomedical Graduate Studies, Cell and Molecular Biology Graduate Group
86 Department of Medicine faculty webpage.
c
1f
Post-Graduate Training
24 43 Intern in Medicine, SUNY Brooklyn, NY, 1978-1979.
24 45 Resident in Medicine, SUNY Brooklyn, NY, 1979-1981.
24 4b Chief Resident in Medicine, SUNY Brooklyn, NY, 1981-1982.
24 56 Fellowship, Hematology/Oncology, New York University, NY, 1982-1986.
24 95 Medical Staff Fellow, National Institute of Child Health and Human Development, National Institute Health, Bethesda, MD, 1986-1989.
24 7e Senior Staff Fellow, National Institute of Child Health and Human Development, NIH, Bethesda, MD, 1989-1992.
24 92 Special Expert, National Institute of Child Health and Human Development, National Institute of Health, Bethesda, MD, 1992-1996.
c
3
25
24 43 Intern in Medicine, SUNY Brooklyn, NY, 1978-1979.
24 45 Resident in Medicine, SUNY Brooklyn, NY, 1979-1981.
24 4b Chief Resident in Medicine, SUNY Brooklyn, NY, 1981-1982.
24 56 Fellowship, Hematology/Oncology, New York University, NY, 1982-1986.
24 95 Medical Staff Fellow, National Institute of Child Health and Human Development, National Institute Health, Bethesda, MD, 1986-1989.
24 7e Senior Staff Fellow, National Institute of Child Health and Human Development, NIH, Bethesda, MD, 1989-1992.
24 92 Special Expert, National Institute of Child Health and Human Development, National Institute of Health, Bethesda, MD, 1992-1996.
c
17
Certifications
28 3c American Board of Internal Medicine, 1981.
28 23 Hematology, 1984.
28 21 Oncology, 1985.
c
3
8b
Permanent link28 3c American Board of Internal Medicine, 1981.
28 23 Hematology, 1984.
28 21 Oncology, 1985.
c
2 29
21
1e
1d
24
5e
63 Study of iron metabolism, iron trafficking, mitochondrial function, heme and Fe-S proteins.
8
82 Key words: mitochondria, yeast, Fe-S, heme, frataxin, mitochondrial carrier proteins, pyrimidines, ring sideroblast
8
24 Research description:
93 In most eukaryotes (including yeast and human cells) the essential iron containing cofactors, Fe-S and heme, are made in the mitochondria.
3e1 Iron transport across the ion impermeable inner membrane (from cytoplasm into the mitochondrial matrix) is an essential process for cell viability and yet it is poorly characterized. This is surprising but, in fact, calcium transport into mitochondria is only beginning to be understood this year. We have found candidate mitochondrial iron transporters and we are developing assays measuring iron import and iron use in mitochondria. An unanticipated connection to pyrimidine exchange has been discovered and this is a current focus of research. A second object of study is to understand Fe-S cluster biogenesis in mitochondria. Frataxin, a disease gene involved in neurodegeneration, has been implicated in Fe-S cluster assembly. We discovered a bypass mutation that enhances formation of the cluster scaffold intermediate. Further in depth study of how this frataxin bypass occurs should shed light on the process of mitochondrial Fe-S cluster assembly and its regulatory controls.
8
36 Rotation Projects (genetic and biochemical)
a5 1. Genetic screen in yeast involving randomization of Isu1 scaffold and isolation of novel suppressor mutants altering Fe-S cluster assembly in mitochondria.
69 2. Genetic screen in yeast for escape from glutaredoxin deficiency in a grx3/4 minus background.
6e 3. Phenotypic evaluation of a library of essential genes for novel iron trafficking genes/functions.
91 4. Purification of a 4 way complex (Nfs1/Isd11/Isu1/Yfh1) and characterization of its activity in Fe-S cluster formation on the scaffold.
65
1a 7 1d 1f
27
Description of Research Expertise
2b Research interests:63 Study of iron metabolism, iron trafficking, mitochondrial function, heme and Fe-S proteins.
8
82 Key words: mitochondria, yeast, Fe-S, heme, frataxin, mitochondrial carrier proteins, pyrimidines, ring sideroblast
8
24 Research description:
93 In most eukaryotes (including yeast and human cells) the essential iron containing cofactors, Fe-S and heme, are made in the mitochondria.
3e1 Iron transport across the ion impermeable inner membrane (from cytoplasm into the mitochondrial matrix) is an essential process for cell viability and yet it is poorly characterized. This is surprising but, in fact, calcium transport into mitochondria is only beginning to be understood this year. We have found candidate mitochondrial iron transporters and we are developing assays measuring iron import and iron use in mitochondria. An unanticipated connection to pyrimidine exchange has been discovered and this is a current focus of research. A second object of study is to understand Fe-S cluster biogenesis in mitochondria. Frataxin, a disease gene involved in neurodegeneration, has been implicated in Fe-S cluster assembly. We discovered a bypass mutation that enhances formation of the cluster scaffold intermediate. Further in depth study of how this frataxin bypass occurs should shed light on the process of mitochondrial Fe-S cluster assembly and its regulatory controls.
8
36 Rotation Projects (genetic and biochemical)
a5 1. Genetic screen in yeast involving randomization of Isu1 scaffold and isolation of novel suppressor mutants altering Fe-S cluster assembly in mitochondria.
69 2. Genetic screen in yeast for escape from glutaredoxin deficiency in a grx3/4 minus background.
6e 3. Phenotypic evaluation of a library of essential genes for novel iron trafficking genes/functions.
91 4. Purification of a 4 way complex (Nfs1/Isd11/Isu1/Yfh1) and characterization of its activity in Fe-S cluster formation on the scaffold.
65
Description of Clinical Expertise
41 diseases of iron metabolism, sideroblastic anemia1a 7 1d 1f